Kronos Bio (KRON) Short Interest Ratio & Short Volume $0.88 +0.02 (+2.06%) (As of 10:28 AM ET) Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Kronos Bio Short Interest DataKronos Bio (KRON) has a short interest of 527,700 shares, representing 1.34% of the float (the number of shares available for trading by the public). This marks a -21.76% decrease in short interest from the previous month. The short interest ratio (days to cover) is 6.4, indicating that it would take 6.4 days of the average trading volume of 269,315 shares to cover all short positions.Current Short Interest527,700 sharesPrevious Short Interest674,500 sharesChange Vs. Previous Month-21.76%Dollar Volume Sold Short$511,869.00Short Interest Ratio6.4 Days to CoverLast Record DateOctober 31, 2024Outstanding Shares60,340,000 sharesFloat Size39,460,000 sharesShort Percent of Float1.34%Today's Trading Volume34,490 sharesAverage Trading Volume269,315 sharesToday's Volume Vs. Average13% Short Selling Kronos Bio? Sign up to receive the latest short interest report for Kronos Bio and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartKRON Short Interest Over TimeKRON Days to Cover Over TimeKRON Percentage of Float Shorted Over Time Ad WealthPressBreaking News: Tesla headed to $500…That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla. So to claim your free digital copy today, simply follow this link and enter your email address. Kronos Bio Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/31/2024527,700 shares $511,869.00 -21.8%1.3%6.4 $0.97 10/15/2024674,500 shares $647,520.00 -5.6%1.7%7.7 $0.96 9/30/2024714,200 shares $714,128.58 -4.6%1.8%5.9 $1.00 9/15/2024748,400 shares $710,979.25 -1.3%1.9%4.9 $0.95 8/31/2024758,500 shares $796,425.00 +7.7%1.9%2.5 $1.05 8/15/2024704,500 shares $695,764.20 -2.0%1.8%2 $0.99 Get the Latest News and Ratings for KRON and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Kronos Bio and its competitors with MarketBeat's FREE daily newsletter. 7/31/2024718,500 shares $934,050.00 -7.8%1.9%1.9 $1.30 7/15/2024779,500 shares $1.12 million +8.2%2.0%1.5 $1.44 6/30/2024720,200 shares $893,048.00 -0.5%1.9%1.4 $1.24 6/15/2024723,500 shares $781,380.00 +5.0%1.9%1.5 $1.08 5/31/2024688,800 shares $544,152.00 -3.5%1.6%1.6 $0.79 5/15/2024714,100 shares $700,817.74 +4.0%1.7%1.6 $0.98 4/30/2024686,800 shares $707,404.00 +3.6%1.7%1.7 $1.03 4/15/2024662,700 shares $755,478.00 -0.4%1.7%1.9 $1.14 3/31/2024665,000 shares $864,500.00 -0.4%1.7%2.6 $1.30 3/15/2024667,800 shares $774,648.00 +11.2%1.7%2.7 $1.16 2/29/2024600,400 shares $624,416.00 -1.8%1.6%2.3 $1.04 2/15/2024611,600 shares $660,528.00 +2.3%1.6%4.1 $1.08 1/31/2024597,700 shares $675,401.00 -74.9%1.6%2.9 $1.13 1/15/20242,380,000 shares $2.81 million -0.4%6.3%10.9 $1.18 12/31/20232,390,000 shares $2.99 million -1.7%6.3%8.8 $1.25 12/15/20232,430,000 shares $3.62 million -10.7%6.4%8.8 $1.49 11/30/20232,720,000 shares $3.24 million -0.4%7.2%10.5 $1.19 11/15/20232,730,000 shares $2.48 million +0.4%7.3%10.6 $0.91 10/31/20232,720,000 shares $2.38 million -1.8%7.0%14 $0.87 10/15/20232,770,000 shares $2.75 million -0.7%7.2%15 $0.99 9/30/20232,790,000 shares $3.63 million -2.1%7.2%18.4 $1.30 9/15/20232,850,000 shares $3.51 million +0.7%7.4%10.7 $1.23 8/31/20232,830,000 shares $3.93 million No Change7.4%10 $1.39 8/15/20232,830,000 shares $4.67 million -1.4%7.4%9.4 $1.65 7/31/20232,870,000 shares $5.51 million -0.7%7.6%9.1 $1.92 7/15/20232,890,000 shares $6.01 million -13.2%7.6%7.1 $2.08 6/30/20233,330,000 shares $5.73 million -21.5%8.7%7.9 $1.72 6/15/20234,240,000 shares $7.21 million +5.2%11.0%10.5 $1.70 5/31/20234,030,000 shares $6.73 million +0.8%10.5%12.7 $1.67 5/15/20234,000,000 shares $7.48 million -5.0%10.4%12.6 $1.87 4/30/20234,210,000 shares $6.95 million -1.9%11.0%13.1 $1.65 4/15/20234,290,000 shares $5.58 million +3.6%11.2%14 $1.30 3/31/20234,140,000 shares $6.04 million +10.4%10.9%13.9 $1.46 3/15/20233,750,000 shares $5.63 million +7.5%9.9%12.3 $1.50JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 2/28/20233,490,000 shares $6.07 million +0.6%9.3%11.5 $1.74 2/15/20233,470,000 shares $7.25 million +1.2%9.3%11.6 $2.09 1/31/20233,430,000 shares $8.23 million -3.7%9.0%12 $2.40 1/15/20233,560,000 shares $9.33 million -0.3%9.4%13.6 $2.62 12/30/20223,570,000 shares $5.78 million -0.8%9.4%15.5 $1.62 12/15/20223,600,000 shares $6.66 million +1.7%9.5%18.7 $1.85 11/30/20223,540,000 shares $6.73 million -2.2%9.3%20.9 $1.90 11/15/20223,620,000 shares $8.65 million -1.4%9.5%20.3 $2.39 10/31/20223,670,000 shares $10.86 million No Change9.3%19.8 $2.96 10/15/20223,670,000 shares $10.42 million -0.3%9.3%17.1 $2.84 9/30/20223,680,000 shares $12.33 million +0.6%9.4%16.2 $3.35 9/15/20223,660,000 shares $17.53 million +3.7%9.3%14.1 $4.79 8/31/20223,530,000 shares $14.12 million +4.1%9.0%10.2 $4.00 8/15/20223,390,000 shares $17.49 million -3.7%8.6%8.3 $5.16 7/31/20223,520,000 shares $14.78 million -9.0%9.0%6.9 $4.20 7/15/20223,870,000 shares $19.12 million -3.7%9.8%7.5 $4.94 6/30/20224,020,000 shares $14.63 million -14.5%10.2%7.7 $3.64 6/15/20224,700,000 shares $15.75 million +2.2%11.9%9 $3.35 5/31/20224,600,000 shares $17.11 million +4.3%11.7%10.4 $3.72 5/15/20224,410,000 shares $17.24 million +2.8%11.0%11.3 $3.91 4/30/20224,290,000 shares $20.29 million +2.4%12.0%13.2 $4.73 4/15/20224,190,000 shares $24.68 million -3.5%11.7%13.8 $5.89 3/31/20224,340,000 shares $31.38 million -5.7%12.2%14.3 $7.23 3/15/20224,600,000 shares $32.84 million -0.9%12.9%15.2 $7.14 2/28/20224,640,000 shares $34.94 million +6.2%13.0%14.1 $7.53 2/15/20224,370,000 shares $30.94 million -6.4%12.1%12.5 $7.08 1/31/20224,670,000 shares $42.50 million -2.3%12.9%15.5 $9.10 1/15/20224,780,000 shares $51.05 million -11.3%13.2%17.3 $10.68 12/31/20215,390,000 shares $73.25 million +2.9%14.9%20.4 $13.59 12/15/20215,240,000 shares $70.79 million +3.8%14.5%19.6 $13.51 11/30/20215,050,000 shares $59.64 million +3.9%13.9%22.5 $11.81 11/15/20214,860,000 shares $81.41 million +10.7%13.4%22.4 $16.75 10/29/20214,390,000 shares $72.26 million +1.6%12.1%21.9 $16.46 10/15/20214,320,000 shares $72.49 million +0.2%11.9%22.9 $16.78 9/30/20214,310,000 shares $90.34 million +5.4%11.9%22.3 $20.96 9/15/20214,090,000 shares $98.08 million -2.2%11.3%16 $23.98 8/31/20214,180,000 shares $87.40 million -5.0%11.5%15 $20.91 8/13/20214,400,000 shares $88.44 million No Change12.1%15.4 $20.10 7/30/20214,400,000 shares $89.98 million -9.7%12.2%15.1 $20.45 7/15/20214,870,000 shares $99.45 million -2.6%13.5%16.4 $20.42 6/30/20215,000,000 shares $119.75 million +12.6%13.9%16.6 $23.95 6/15/20214,440,000 shares $114.06 million +3.5%12.3%16.4 $25.69 5/28/20214,290,000 shares $104.72 million +6.2%11.9%17.3 $24.41 5/14/20214,040,000 shares $102.49 million +6.0%11.2%18.5 $25.37 4/30/20213,810,000 shares $96.96 million -2.8%10.6%18.6 $25.45 4/15/20213,920,000 shares $86.28 million +21.4%11.7%19.6 $22.01 3/31/20213,230,000 shares $89.96 million +18.3%9.7%17.8 $27.85 3/15/20212,730,000 shares $78.27 million +22.4%8.2%13.4 $28.67 2/26/20212,230,000 shares $65.00 million +1.8%6.7%12.5 $29.15 2/12/20212,190,000 shares $65.92 million +7.9%6.6%12.3 $30.10JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. 1/29/20212,030,000 shares $55.48 million +0.5%6.0%10.4 $27.33 1/15/20212,020,000 shares $64.56 million No Change6.0%9.7 $31.96 KRON Short Interest - Frequently Asked Questions What is Kronos Bio's current short interest? Short interest is the volume of Kronos Bio shares that have been sold short but have not yet been covered or closed out. As of October 31st, investors have sold 527,700 shares of KRON short. 1.34% of Kronos Bio's shares are currently sold short. Learn More on Kronos Bio's current short interest. What is a good short interest ratio for Kronos Bio? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. KRON shares currently have a short interest ratio of 6.0. Learn More on Kronos Bio's short interest ratio. What is a good short interest percentage for Kronos Bio? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 1.34% of Kronos Bio's floating shares are currently sold short. Is Kronos Bio's short interest increasing or decreasing? Kronos Bio saw a decrease in short interest in October. As of October 31st, there was short interest totaling 527,700 shares, a decrease of 21.8% from the previous total of 674,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Kronos Bio's float size? Kronos Bio currently has issued a total of 60,340,000 shares. Some of Kronos Bio's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Kronos Bio currently has a public float of 39,460,000 shares. How does Kronos Bio's short interest compare to its competitors? 1.34% of Kronos Bio's shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Kronos Bio: Sutro Biopharma, Inc. (2.91%), TScan Therapeutics, Inc. (5.19%), Amarin Co. plc (4.37%), SOPHiA GENETICS SA (0.05%), Inhibrx, Inc. (9.70%), Acrivon Therapeutics, Inc. (4.97%), Solid Biosciences Inc. (4.40%), XBiotech Inc. (4.29%), Corbus Pharmaceuticals Holdings, Inc. (20.17%), MacroGenics, Inc. (9.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.08 billion), AppLovin Co. ($3.18 billion), Paychex, Inc. ($2.64 billion), Nu Holdings Ltd. ($2.54 billion), International Paper ($2.46 billion), Cencora, Inc. ($2.27 billion), Moderna, Inc. ($1.87 billion), SoFi Technologies, Inc. ($1.81 billion), Lululemon Athletica Inc. ($1.75 billion), and Onsemi ($1.71 billion). View all of the most shorted stocks. What does it mean to sell short Kronos Bio stock? Short selling KRON is an investing strategy that aims to generate trading profit from Kronos Bio as its price is falling. KRON shares are trading up $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Kronos Bio? A short squeeze for Kronos Bio occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of KRON, which in turn drives the price of the stock up even further. How often is Kronos Bio's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including KRON, twice per month. The most recent reporting period available is October, 31 2024. More Short Interest Resources from MarketBeat Related Companies Sutro Biopharma Short Interest Data TScan Therapeutics Short Interest Data Amarin Short Interest Data SOPHiA GENETICS Short Interest Data Inhibrx Short Interest Data Acrivon Therapeutics Short Interest Data Solid Biosciences Short Interest Data XBiotech Short Interest Data Corbus Pharmaceuticals Short Interest Data MacroGenics Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:KRON) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Kronos Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Kronos Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
